Preventive care can transform population health—but too often it stalls between promising ideas and scalable results. Join this panel to explore the Evidence-Based Prevention Continuum, a new framework developed by the Health Care Payment Learning & Action Network (HCPLAN) in partnership with the CMS Innovation Center (CMMI) and leaders across health plans, health systems, academia, federal agencies, and advocacy organizations. Panelists will discuss five levels of evidence (from “Opinion-Informed” to “Scaled Evidence-Based”) and will share how preventive interventions fall into different stages on a “Pathway to Scale”—clarifying which payers, funders, and mechanisms can move prevention forward at each stage. You’ll also learn how quality measures can be used not just for reporting, but as a strategic lever to pilot emerging interventions and accelerate adoption of those with stronger evidence—while navigating real-world barriers like member churn, lagged outcomes, attribution challenges, and budgeting cycles. Walk away with actionable insights to better measure, fund, and scale prevention in ways that improve beneficiary outcomes and align with operational and regulatory realities.

Key Takeaways:

• Not all preventive interventions are ready for the same scaling approach; matching the intervention's level of evidence to the right funder/payment mechanism and quality measure strategy is essential to avoid both premature scaling and missed opportunities.
• Quality measures are not just a reporting requirement; they are a practical tool for generating implementation evidence and driving payment alignment around prevention.
• Cross-sector collaboration across payers, clinicians, federal partners, and patients is necessary to build preventive interventions that are both clinically credible and operationally feasible at scale.